DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 -12.46 -0.28%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

12.07 -0.52 (-4.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $12.07 -4.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.58
Previous Close $12.59
Daily Range $12.06 - $12.63
52-Week Range $8.87 - $15.34
Market Cap $1.5B
P/E Ratio -10.67
Dividend (Yield) $0.00 (0.0%)
Volume 1,369,200
Average Daily Volume 1,345,371
Current FY EPS -$0.65

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Update: AstraZeneca Moves Closer To EU Approval For Moventig

Nektar/AstraZeneca's Moventig a Step Closer to EU Approval - Analyst Blog

Interesting NKTR Put And Call Options For May 2015

Sector Update: Health-Care Stocks Mixed Pre-Market

Nektar Therapeutics (NKTR) Shares Cross Below 200 DMA

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 20

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

Nektar 181 Could Dominate A $13B Chronic Pain Market

See More NKTR News...

NKTR's Top Competitors

NKTR $12.07 (-4.13%)
Current stock: NKTR
TMO $121.70 (-0.25%)
Current stock: TMO
$0.00 (0.00%)
Current stock:
ILMN $163.92 (-0.79%)
Current stock: ILMN